Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report

Transplant Proc. 2014 Sep;46(7):2368-70. doi: 10.1016/j.transproceed.2014.07.060.

Abstract

Encapsulating peritoneal sclerosis is a serious complication of peritoneal dialysis and can occur even after transplant. The gut is partially or totally enveloped by a thick fibrous membrane that leads to the formation of multiple sections containing intestinal loops contracted and reduced in volume. Exacerbation after renal transplantation is a very rare but sometimes dramatic condition. We report a patient who developed intestinal obstruction due to encapsulating peritoneal sclerosis 1 year after a deceased-donor kidney transplant. Treatment included laparotomy, small-bowel lengthening by release of adhesions, and high doses of corticosteroids. The patient received immunosuppressive therapy with a combination of low-dose cyclosporine, everolimus, and prednisone, unchanged except for a temporary steroid increase in the postoperative period. We report success with this combined surgical plus medical therapy, with no recurrence after 81 months of follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Calcineurin Inhibitors / administration & dosage*
  • Cyclosporine / administration & dosage*
  • Drug Therapy, Combination
  • Everolimus
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Intestinal Obstruction / etiology
  • Kidney Transplantation
  • Peritoneal Dialysis
  • Peritoneal Fibrosis / complications
  • Peritoneal Fibrosis / drug therapy*
  • Prednisone / administration & dosage
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use

Substances

  • Calcineurin Inhibitors
  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclosporine
  • Everolimus
  • Prednisone
  • Sirolimus